INM earnings
InMed Pharmaceuticals (INM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- INM reports next on Feb 16, 2027, with EPS of -944.44 expected.
- INM beat EPS estimates in 4 of its last 7 reports.
INM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q1 2027 | Nov 16, 2026 | -0.42 | – | – | – |
| Q3 2026 | May 6, 2026 | -0.69 | -944.44 | 99.93% | $1.26M |
| Q2 2026 | Feb 11, 2026 | -0.51 | – | – | $820.19K |
| Q1 2026 | Nov 6, 2025 | -0.44 | – | – | $1.12M |
| Q3 2025 | May 12, 2025 | -1.94 | – | – | $1.26M |
| Q2 2025 | Feb 12, 2025 | -3.64 | – | – | $1.11M |
| Q1 2025 | Nov 14, 2024 | -54.20 | 15.41 | -451.72% | $1.26M |
| Q4 2024 | Sep 27, 2024 | -3.80 | -850.00 | 99.55% | $1.28M |
| Q3 2024 | May 14, 2024 | -3.60 | 13.43 | -126.81% | $1.17M |
| Q2 2024 | Feb 13, 2024 | -3.80 | 15.76 | -124.11% | $1.24M |
| Q1 2024 | Nov 14, 2023 | -15.20 | – | – | $901.86K |
| Q2 2023 | Feb 17, 2023 | -18.20 | -90.00 | 79.78% | $469.78K |
| Q1 2023 | Nov 11, 2022 | -81.20 | -85.00 | 4.47% | $320.79K |